APP and Alzheimer disease: For example, Park et al. recently reported that injection of the newly synthesized reversible MAO-B inhibitor KDS2010 in APP/PS1 mice (a mouse model of AD) significantly suppresses astrocytic GABA upregulation and astrogliosis and rescues learning and memory [48].